Close Menu

NEW YORK – Digital health company Everlywell announced Friday it has signed an agreement with Ginkgo Bioworks to distribute Access Bio's CareStart COVID-19 antigen test to organizations in need of SARS-CoV-2 diagnostic tests. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.